Angiogenic Host Defense Peptide Ag-30/5C and Bradykinin B 2 receptor Antagonist Icatibant are G Protein Biased Agonists for MRGPRX2 in Mast Cells

Thumbnail Image
Penn collection
Departmental Papers (Dental)
Degree type
Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Cells
Cultured; HEK293 Cells; Humans; Mast Cells; Nerve Tissue Proteins; Peptides; Rats; Receptors
G-Protein-Coupled; Receptors
Grant number
Copyright date
Related resources
Roy, S.
Ganguly, A.
Haque, M.
Ali, H.

AG-30/5C is an angiogenic host defense peptide that activates human mast cells (MC) via an unknown mechanism. Using short hairpin RNA–silenced human MC line LAD2 and stably transfected RBL-2H3 cells, we demonstrate that AG-30/5C induces MC degranulation via Mas-related G protein–coupled receptor X2 (MRGPRX2). Most G protein–coupled receptors signal via parallel and independent pathways mediated by G proteins and b-arrestins. AG-30/5C and compound 48/80 induced similar maximal MC degranulation via MRGPRX2, which was abolished by pertussis toxin. However, compound 48/80 induced a robust b-arrestin activation as determined by transcriptional activation following arrestin translocation (Tango), but AG-30/5C did not. Overnight culture of MC with compound 48/80 resulted in reduced cell surface MRGPRX2 expression, and this was associated with a significant decrease in subsequent MC degranulation in response to compound 48/80 or AG-30/5C. However, AG-30/5C pretreatment had no effect on cell surface MRGPRX2 expression or degranulation in response to compound 48/80 or AG-30/5C. Icatibant, a bradykinin B 2 receptor antagonist, promotes MC degranulation via MRGPRX2 and causes pseudoallergic drug reaction. Icatibant caused MC degranulation via a pertussis toxin–sensitive G protein but did not activate b-arrestin. A screen of the National Institutes of Health Clinical Collection library led to the identification of resveratrol as an inhibitor of MRGPRX2. Resveratrol inhibited compound 48/80–induced Tango and MC degranulation in response to compound 48/80, AG-30/5C, and Icatibant. This study demonstrates the novel finding that AG-30/5C and Icatibant serve as G protein–biased agonists for MRGPRX2, but compound 48/80 signals via both G protein and b-arrestin with distinct differences in receptor regulation. Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved

Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
Journal title
Journal of Immunology
Volume number
Issue number
Publisher DOI
Journal Issue
Recommended citation